PSA Today Sep 16: Focus on Frontier tech as Snowflake prices well / Artificial glass eels! / DSK's P2 trails for colorectal drug / Subaru faces class action lawsuit – Nikkei +0.09%
Japan Market Comment by Pelham Smithers and Julie BooteNikkei ¥23,475.53 (+¥20.64 / +0.09%); Topix ¥1,644.35 (+¥3.51 / +0.21%); ¥/$105.18
Tags: Snowflake Inc (SNOW US), Ajinomoto (2802 JT), Canon (7751 JT), Sony (6758 JT), Square Enix (9684 JT), Huawei, TDK (6762 JT), Apple (AAPL US), M3 Inc (2413 JT), Medley (4480 JT), GA Technologies (3491 JT), SRE Holdings (2980 JT), Takeda (4502 JT), Corza Health, Johnson & Johnson (JNJ US), Shin Nippon Biomedical Laboratories (2395 JT), Daiichi Sankyo (4568 JT), Chugai Pharmaceutical (4519 JT), Ono Pharmaceutical (4528 JT), Eisai (4523 JT), Shionogi (4507 JT), Subaru (7270 JT), Tesla (TSLA US), Toyota Motor (7203 JT)
Main Points
• Frontier tech stocks to the fore as Snowflake prices at US$120/shr
• Artificial glass eel breeding achieved
• DSK begins P2 trials for Patritumab Deruxtecan
• Subaru faces unintended acceleration lawsuit
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.